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Stenosis coexists with compromised 
α1-adrenergic contractions in the 
ascending aorta of a mouse model of 
Williams-Beuren syndrome
Francesc Jiménez-Altayó  1*, Paula ortiz-Romero2,3,7, Lídia puertas-Umbert1,7,  
Ana Paula Dantas4, Belén pérez1, Elisabet Vila1, Pilar D’ocon5 & Victoria campuzano  2,3,6*
Williams-Beuren syndrome (WBS) is a rare disorder caused by a heterozygous deletion of 26–28 
contiguous genes that affects the brain and cardiovascular system. Here, we investigated whether 
WBS affects aortic structure and function in the complete deletion (CD) mouse model harbouring the 
most common deletion found in WBS patients. Thoracic aortas from 3–4 months-old male CD mice and 
wild-type littermates were mounted in wire myographs or were processed for histomorphometrical 
analysis. Nitric oxide synthase (NOS) isoforms and oxidative stress levels were assessed. Ascending 
aortas from young adult CD mice showed moderate (50%) luminal stenosis, whereas endothelial 
function and oxidative stress were comparable to wild-type. CD mice showed greater contractions to 
KCl. However, α1-adrenergic contractions to phenylephrine, but not with a thromboxane analogue, 
were compromised. Decreased phenylephrine responses were not affected by selective inducible NOS 
blockade with 1400 W, but were prevented by the non-selective NOS inhibitor L-NAME and the selective 
neuronal NOS inhibitor SMTC. Consistently, CD mice showed increased neuronal NOS expression in 
aortas. Overall, aortic stenosis in CD mice coexists with excessive nNOS-derived NO signaling that 
compromises ascending aorta α1-adrenergic contractions. We suggest that increased neuronal NOS 
signaling may act as a physiological ‘brake’ against the detrimental effects of stenosis.
Williams-Beuren syndrome (WBS) [OMIM 194050] is a rare congenital multisystem disorder caused by a recur-
rent heterozygous deletion of 26–28 contiguous genes on chromosome band 7q11.231. This syndrome affects 
males and females equally with a prevalence that is estimated to range between 1/7,500 and 1/10,0002. Mainly 
due to elastin (ELN) haploinsufficiency, this condition is commonly characterized by cardiovascular alterations 
that can occur early in life3, can evolve into potentially serious complications, and are the main cause of death 
in WBS patients1,4. Supravalvular aortic stenosis is the most frequent cardiovascular anomaly, affecting approx-
imately 70% of patients1,5, and it is a potentially life-threatening condition6,7. Surgery may be required and drug 
treatments for this disorder and other cardiovascular manifestations in WBS generally not differ from that in the 
general population8. Therefore, a thorough analysis of the pathophysiological mechanisms of aortic disease in 
WBS is needed to define more safe and effective personalized therapies.
Mouse models of elastin deficiency have provided valuable insights into the mechanisms responsible for 
the development of aortic anomalies in WBS. Thus, partial rescue of Eln−/− by transgenic expression of human 
ELN9,10 is sufficient to cause a similar aortic phenotype to typical WBS patients11–15. However, there is increasing 
evidence that other genes besides Eln may be relevant in modulating the WBS cardiovascular phenotype. Various 
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mouse models carrying chromosome microdeletions affecting the WBS critical region have been generated to 
mimic the molecular defects present in patients16,17. Mice carrying a heterozygous distal deletion (DD) (from 
Limk1 to Trim50) are hypertensive, show increased aortic oxidative stress levels, cardiac hypertrophy, decreased 
aortic compliance, and histological alterations characterized by aortic wall thickening and fragmentation of 
elastin lamellar units18,19. However mice carrying a complete deletion (CD) (from Gtf2i to Fkbp6) show mild 
hypertension and cardiac hypertrophy at 8 months of age17. Notably, aortic function has never been explored in 
the ascending aorta of either CD mice or other mouse models carrying WBS chromosome microdeletions. The 
identification of early aortic dysfunction in WBS may help predict and prevent disease-related cardiovascular 
problems.
Previous evidence suggests a role of aortic valve endothelium in the maintenance of valvular homeostasis20. 
The endothelium releases a number of vasoactive substances including nitric oxide (NO), which is a signaling 
molecule that has many beneficial and sometimes detrimental effects on cardiovascular function21,22. NO plays 
an important role in the decreased ability of a vessel to respond to persistent stimulation by α1-adrenoceptor 
agonists, a process called ‘NO-mediated desensitization’23. Moreover, in aorta, a modulatory role of neuronal NOS 
(nNOS) associated to activation of the α1A-adrenoceptor subtype has been proposed as a physiological ‘brake’ 
against the detrimental effects of excessive adrenergic vasoconstriction24. Remarkably, an impairment of NO 
responsiveness is reported in patients with aortic stenosis25–27, and a proportion of WBS patients manifest higher 
levels of oxidative stress28; effects that might be associated with aortic dysfunction. Deep understanding of devel-
opment of functional aortic anomalies in animal models of WBS and exploration of the mechanisms potentially 
involved would identify proper targets for human therapy.
In the present study, we provide the first comprehensive assessment of thoracic aorta structure and reactivity 
in young CD mice, a mouse model carrying the most common deletion found in WBS patients, which often man-
ifest cardiovascular disease early in life. We conclude that ascending aortas from young CD mice show stenosis 
and impaired phenylephrine-induced α1-adrenergic contractions because of a NO-mediated desensitization.
Methods
Animals. Three- to four-months old male heterozygous CD (n = 25) mice and age-matched wild-type (WT, 
n = 26) littermates were used. Genotyping was made as previously reported29. Mice were housed according to 
institutional guidelines (constant room temperature at 22 °C, 12 h: 12 h light-dark cycle, 60% humidity, and 
access to food and water ad libitum). Experimental procedures were approved by the Ethical Committee of the 
Parc de Recerca Biomèdica de Barcelona (PRBB, Barcelona, Spain). The PRBB has Animal Welfare Assurance 
(#A5388–01, Institutional Animal Care and Use Committee approval date 05/08/2009), granted by the Office 
of Laboratory Animal Welfare (OLAW) of the US National Institutes of Health. The research conforms to the 
European Commission Directive 86/609 CEE Art. 21 (1995) and the Guide for the Care and Use of Laboratory 
Animals published by the US National Institutes of Health (NIH Publication No. 85–23, revised 1996). All exper-
iments of this study were carried out in a blinded fashion.
Blood pressure measurements in conscious mice. Measurement of systolic blood pressure was per-
formed in conscious WT and CD mice using the tail-cuff method (NIPREM 645; Cibertec, Madrid, Spain). The 
average systolic blood pressure of each mouse was determined from six consecutive measurements after habitu-
ation, as described30.
Tissue preparation. Segments (Fig. 1A) of the ascending aorta (histomorphometry, reactivity, elastin aut-
ofluorescence, Western blot, and qRT-PCR), aortic arch (immunofluorescence and dihydroethidium), and the 
descending aorta (histomorphometry) were dissected free of fat and connective tissue and placed in ice-cold 
Krebs Henseleit solution gassed with a 95% O2–5% CO2 mixture. Aortic segments used for immunofluorescence 
studies were fixed with 4% phosphate buffered paraformaldehyde for 1 h, washed in three changes of phosphate 
buffered saline solution, and processed as described31. Plasma (200 μl) was collected after decapitation and was 
kept at −70 °C until the day of analysis of circulating superoxide anion levels by high-performance liquid chro-
matography (HPLC).
Ex vivo gross examination of the proximal thoracic aorta. After dissection, images of the thoracic 
aorta were obtained ex vivo using a dissecting microscope (Leica, Wetzlar, Germany). The length of the prox-
imal thoracic aorta (i.e. ascending aorta and aortic arch) was measured along its medial curvature from the 
ventricular-aortic junction to the distal aortic arch that finishes when the inner and outer curvature become 
parallel. Aortic length was measured from calibrated digital images using ImageJ 1.51j8 (National Institutes of 
Health, Bethesda, MD, USA) software.
Measurement of elastin autofluorescence and number of elastin laminae. Total elastin con-
tent was studied in aortic cross-sections (14 μm-thick) based on the autofluorescent properties of elastin, as 
described32. Values of fluorescence intensity were estimated as a measure of elastin concentration, following 
the assumption that the concentration of elastin has a linear relationship with fluorescence intensity33. All of 
the images were taken using a laser-scanning confocal microscope (×20 objective; Leica TCS SP5, Manheim, 
Germany) under identical conditions of zoom (×1), laser intensity, brightness, and contrast. Quantitative anal-
ysis of elastin autofluorescence and number of elastin laminae was performed with ImageJ 1.51j8 software. The 
average intensity of fluorescence signal (expressed as arbitrary units) and the number of elastin laminae were 
measured in at least three rings from each animal.
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Aortic histomorphometry. Morphometric determination of aortic vessel and lumen area, and 
cross-sectional area (CSA) was performed using hematoxylin and eosin staining. Images were obtained with a 
Nikon Eclipse 80i microscope (×4 objective) and analyzed using ImageJ 1.51j8 software. The luminal and the ves-
sel area, delimited by the internal elastic lamina and the external hematoxylin and eosin stained area, respectively, 
were calculated assuming a circle and applying the formula l2/4π, where l is the perimeter of the delimiting area, 
as described34–36. This correction circumvents inaccuracies in structural parameters calculations caused by the 
eventual collapse of the immersion-fixed arteries34. Wall thickness was calculated as follows: wall thickness = (De 
− Di)/2, where De and Di are the external and internal diameter, respectively. De and Di were extrapolated from 
the following formula: A = π·(D/2)2, where A is the vessel (Ae) or the lumen (Ai) area. The CSA was calculated as 
follows: CSA = Ae − Ai. At least three sections from each artery/animal were measured.
RNA preparation and gene expression quantification by qRT-PCR. RNA was extracted from 
ascending aortas using RNeasy Micro Kit (Qiagen, Hilden, Germany) according to the manufacturer’s instruc-
tions. cDNA was prepared from 1 µg of total RNA using random hexamers and SuperScript II RNase H reverse 
transcriptase (Invitrogen). The expression of Adra1a (α1A-adrenoceptors), Limk1 (a gene contained in the 
WBS commonly deleted region) and Rps28 (internal control) was evaluated by quantitative PCR (qRT-PCR), as 
described17, using the appropriate primers (Supplementary Table S1). Each PCR was made with triplicates from 
two different RTs. The expression values were relativized according to the average expression of the WT animals 
for each gene.
Analysis of circulating 2-hydroxyethidium (2-EOH). Plasma levels of 2-EOH (Sigma-Aldrich, St. 
Louis, MO, USA) were assessed by HPLC with fluorescence detection, as a quantitative measure of plasma super-
oxide anion levels, as described37–39. 2-EOH present in the samples was quantified by comparing with a calibra-
tion curve based on the reaction xanthine-xanthine oxidase from the method described by Michalski and cols40.
Figure 1. General characteristics of thoracic aortas from wild-type and CD mice. (A) Diagram illustrating the 
thoracic aorta segments used in the study. (B) Pictures showing representative ex vivo aortas and quantification 
of the proximal thoracic aorta length. Scale bar, 1 unit = 0.1 mm. Results are the mean ± SEM from wild-
type (n = 4) and CD (n = 5) mice. *P < 0.05 by Student’s t-test. (C) Representative photomicrographs and 
quantification of elastin autofluorescence (green; bottom left) and number of elastin laminae (bottom right) in 
confocal microscopic ascending aorta sections. Scale bar, 40 μm. Results are the mean ± SEM from wild-type 
(n = 5) and CD (n = 6) mice. **P < 0.01 by Mann-Whitney U test.
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Measurement of aortic oxidative stress. The oxidative fluorescent dye dihydroethidium (DHE; 
Sigma-Aldrich) was used to evaluate in situ production of superoxide anion in non-fixed 14 μm-thick aor-
tic sections, as described41. Quantitative analysis of DHE-derived fluorescence in images obtained using a 
laser-scanning confocal microscope (×20 objective; Olympus FluoView 1000; Olympus, Shinjuku, Tokio, Japan) 
was performed with ImageJ 1.51j8 software. At least three rings from each animal were measured and the results 
were expressed as arbitrary units.
Aortic reactivity. Segments (2 mm) of the ascending thoracic aorta were set up on an isometric wire myo-
graph (model 410 A; Danish Myo Technology, Aarhus, Denmark) filled with KHS (37 °C; 95% O2 and 5% CO2), 
as described42. Optimal tension was assessed in preliminary experiments by subjecting arterial segments to dif-
ferent resting tensions and challenging with 100 mM KCl41,43. The optimal tension of the ascending aorta was the 
same for WT and CD mice (5 mN). Therefore, the vessels were stretched to 5 mN, washed and allowed to equil-
ibrate for 45 min. The tissues were contracted twice (10-min interval) with 100 mM KCl. After washing, vessels 
were left to equilibrate for a further 30 min before starting the experiments. Endothelial-dependent vasodilata-
tions to acetylcholine (ACh; 10−9 to 10−5 M) were performed in phenylephrine-precontracted vessels to induce 
70–100% of 100 mM KCl contraction, and thus produce a similar level of precontraction in either group. The 
use of thromboxane A2 mimetic 9,11-Dideoxy-9α,11α-methanoepoxyprostaglandin F2α (U46619) to contract 
the vessels was discarded, because of U46619-induced precontractions greatly reduced ACh-induced vasodila-
tations. Agonist-induced contractile responses were studied by evaluating stimulation of α1-adrenoceptors with 
phenylephrine (10−9 to 3 × 10−5 M) or thromboxane A2 receptors with U46619 (10−9 to 3 × 10−6 M). The effects 
of the non-selective nitric oxide synthase (NOS) inhibitor Nω-nitro-l-arginine methyl ester (L-NAME; 3 × 10−4 
M)41, the selective iNOS inhibitor 1400 W (10−5 M)41, and the selective nNOS inhibitor SMTC (10−6 M)24 were 
determined by adding each treatment 30 min before phenylephrine- or ACh-induced responses.
Western blot. Similar amount of protein from each cell sample (20 µg) was resolved by SDS -PAGE on 
4–12% gels and electroblotted onto nitrocellulose. Before immunoblotting, all membranes were labeled using a 
No-StainTM Protein Labeling Reagent (ThermoFisher scientific, Waltham, MA, USA) and fluorescent signal at 
590 nm was used as a loading control. After washings and blocking with 2% casein solution in phosphate-buffered 
saline (PBS), membranes were incubated overnight at 4 °C in PBS with 0.1% (v/v) Tween 20 (PBST) containing 
1% casein and specified primary antibodies as follows: 1:1000 mouse anti-eNOS (BD Biosciences, Franklin Lakes, 
NJ, USA, # 610297); 1:1000 rabbit anti-iNOS (ThermoFisher scientific, Waltham, MA, USA, #PA1-036); or 1:1000 
mouse anti-nNOS (ThermoFisher scientific, Waltham, MA, USA, #37–2800). After incubation with horseradish 
peroxidase-labelled specific secondary antibodies in PBST containing 1% casein and additional washes, chemi-
luminescent signal was visualized by LAS4000 imaging system (Fujifilm, Barcelona, Spain). Densitometry of 
Western blots was performed using the ImageJ 1.51j8 Software. Data were normalized to corresponding values 
of total protein densitometry.
Immunofluorescence. Fourteen-μm-thick aortic cross sections were obtained in a cryostat and were 
blocked with a 5% solution of bovine serum albumin (Sigma-Aldrich). Afterwards, sections were incubated with 
mouse monoclonal anti-eNOS (1:100; BD Biosciences, Franklin Lakes, NJ, USA, #610297), or a rabbit polyclonal 
anti-iNOS (1:50; ThermoFisher scientific, Waltham, MA, USA, #PA1-036) and anti-nNOS (1:100; ThermoFisher 
scientific, Waltham, MA, USA, #61-7000) antibodies at 37 °C, as described41. After washing, slides were treated 
with an anti-mouse (#715-165-150) or anti-rabbit (#711-165-152) Cy3™ secondary antibody (1:200; Jackson 
ImmunoResearch Laboratories Inc., West Grove, PA, USA). Sections were mounted with fluorescence mounting 
medium (Code S3023; Dako, Agilent, Santa Clara, CA, USA). Images were captured with an Olympus FluoView 
1000 confocal system (×20 objective; Olympus, Shinjuku, Tokio, Japan). Several fluorescent regions between elas-
tin laminae of the smooth muscle layer, and within the endothelium were delineated and averaged using ImageJ 
1.51j8 software. Then, the global average intensity in at least three sections per animal was obtained.
Statistical analysis. Data are presented as mean ± SEM of the number (n) of mice shown in figure legends. 
Vasodilator responses to ACh were expressed as a percentage of the previous tone generated by phenylephrine. 
Sigmoid curve fitting (variable slope) was performed by non-linear regression to obtain maximal responses (Emax) 
and sensitivity (pEC50). Preliminary testing for normality was performed before using Mann-Whitney U test or 
Student’s t-test to compare the mean difference between two groups. Multiple t-test followed by Sidak-Bonferroni 
test as post hoc was used in the analysis of qRT-PCR data. Differences between concentration-response curves 
were also assessed by two-way repeated measures ANOVA followed by Bonferroni’s test as post hoc. The software 
GraphPad Prism 8 (GraphPad Software Inc., La Jolla, CA, USA) was used to run statistical analyses. A value of 
P < 0.05 was considered as statistically significant.
Results
In agreement with a previous report17, young adult (3–4 months-old) CD mice showed significantly reduced 
(P < 0.001) body weight compared to WT mice (Supplementary Fig. S1A). There were no significant differences 
in systolic blood pressure between groups (Supplementary Fig. S1B).
Young CD mice exhibited alterations in thoracic aorta morphology. The proximal thoracic aorta, 
including the ascending aorta and the aortic arch, from CD mice was longer (P < 0.05; Fig. 1B) and showed 
reduced (P < 0.01) elastin autofluorescence and increased (P < 0.01) number of elastin laminae in the ascending 
aorta (Fig. 1C). Compared to WT mice, CD mice ascending aortas showed smaller vessel (P < 0.01; results not 
shown) and lumen (P < 0.01; Fig. 2A,B) areas, whereas wall thickness and CSA were not significantly altered 
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(Fig. 2A,B). In contrast, descending aorta structure was similar between genotypes (Fig. 2A). These results suggest 
the presence of ascending aorta stenosis in CD mice.
CD mice showed unaltered oxidative stress levels. Plasma levels of 2-EOH, an indirect measure of 
circulating superoxide anions37,39, were similar between genotypes (Fig. 3A). To assess in situ oxidative stress 
production, we evaluated aortic wall oxidative stress formation by studying DHE-derived fluorescence (Fig. 3B). 
Aortas from CD mice showed similar levels of DHE fluorescence compared to WT mice. Altogether, these data 
suggest that CD mice do not show altered levels of either circulating or aortic oxidative stress.
Endothelial function was preserved in aortas from CD mice. There were no differences in 
endothelium-dependent ACh-induced vasodilatation in the aorta of CD and WT mice (Fig. 4; Table 1). The 
non-selective NOS inhibitor L-NAME (3 × 10−4 M) greatly decreased (P < 0.001) ACh-induced vasodilatation 
in either group (Fig. 4) indicating that in both genotypes the ACh-induced vasodilatation is mediated by NO 
signaling. These results suggest that endothelial function is preserved in CD mice.
Contractile responses were altered in aortas from CD mice. Contractile responses to KCl (100 mM) 
were significantly higher (P < 0.05) in CD compared to WT aortas (Fig. 5A). Despite enhanced KCl responses, 
concentration-dependent contractions to phenylephrine were markedly decreased in the aorta of CD compared 
to WT mice (Fig. 5B), since the Emax of CD mice aortas was significantly lower (P < 0.001) than that of WT aortas 
(Table 1). In contrast, contractions to U46619 were similar between groups (Fig. 5C; Table 1). These findings sug-
gest that there is a lower aortic vasoconstriction specific to α1-adrenergic-mediated responses.
NO-mediated modulation of phenylephrine contractions was increased in CD mice. In the 
thoracic aorta, phenylephrine contractile responses are counteracted by NO release, as evidenced by treat-
ment of arterial rings with L-NAME (3 × 10−4 M), which enhanced (i.e. higher Emax; Fig. 6A, Table 2) the 
concentration-response curve to phenylephrine in both WT and CD mice. Notably, L-NAME treatment reversed 
the impairment of phenylephrine contractions observed in CD mice, as in these conditions, no contractile dif-
ferences were observed between groups (Fig. 6A, Table 2). To elucidate the source of NO involved in contractile 
differences, we then evaluated the effects of the selective iNOS inhibitor 1400 W (10−5 M) that had no effect 
on phenylephrine-induced contractions in either group (Fig. 6B, Table 2). In contrast, treatment with SMTC 
(10−6 M), a selective nNOS inhibitor, increased (P < 0.05) the Emax of phenylephrine contractions in WT and CD 
mice, an effect that prevented compromised aortic contractions in CD mice (Fig. 6C, Table 2). Taken together, 
Figure 2. Structural characteristics of thoracic aortas from wild-type and CD mice. (A) morphometric analysis 
of the lumen area, wall thickness, and cross-sectional area of ascending and descending aorta histological 
sections stained with hematoxylin and eosin. Results are the mean ± SEM from wild-type (n = 5) and CD 
(n = 6) mice. **P < 0.01 by Mann-Whitney U test. (B) Representative photomicrographs of ascending aorta 
histological sections. Scale bar, 100 μm.
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these results suggest that NO-mediated negative feedback underlies impaired phenylephrine contractions in CD 
mice, an effect that depends on nNOS activation.
Increased levels of α1A-adrenoceptor and nNOS were found in aortas from CD mice. A mod-
ulatory role of nNOS associated to activation of the α1A-adrenoceptor subtype in aorta has been proposed as a 
physiological ‘brake’ against the detrimental effects of excessive adrenergic vasoconstriction24. We observed an 
increase (P < 0.05) in aortic Adra1a (α1A-adrenoceptors) mRNA levels in CD compared to WT mice (Fig. 7A). 
On the other hand, aortic expression of nNOS was also increased (P < 0.05) in CD mice (Fig. 7B), and was 
detected in both endothelial and smooth muscle cell layers (Fig. 7C). The fluorescence signaling was more marked 
in CD mice, particularly in the endothelium (Fig. 7C). Consistently, quantitative analysis of fluorescence showed 
greater levels (P < 0.05) of nNOS expression in aortas from CD compared to WT mice (Fig. 7C). However, similar 
Figure 3. Oxidative stress levels in plasma and thoracic aortas from wild-type and CD mice. (A) Plasma levels 
of 2-hydroxyethidium (2-EOH). Results are mean ± SEM from wild-type (n = 9) and CD (n = 10) mice. (B) 
Representative photomicrographs and quantification of fluorescence (red) intensity of confocal microscopic 
sections labelled with the oxidative dye dihydroethidium (DHE). Scale bar: 20 µm. Results are the mean ± SEM 
from wild-type (n = 9) and CD (n = 8) mice.
Figure 4. Endothelium-dependent relaxation and influence of nitric oxide synthase (NOS) inhibition in 
ascending aortas from wild-type and CD mice. Concentration-response curves to acetylcholine were evaluated 
in the absence and presence of the nonselective nitric oxide synthase inhibitor L-NAME (3 × 10−4 M). Results 
are the mean ± SEM from wild-type (n = 5–15) and CD (n = 4–13) mice. ***P < 0.001 by two-way ANOVA.
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levels of iNOS (equally distributed in all layers of the aortic wall) and eNOS (mainly located in the endothelium 
layer) were observed in WT and CD mice (Fig. 7C; Supplementary Fig. S2).
Discussion
Several mice models carrying chromosome microdeletions affecting the WBS critical region have been gener-
ated16,17. These models are crucial to study potential alterations in vascular responses associated with WBS, a 
significant question that has not yet been fully addressed. The present study examined ascending aorta structure 
and reactivity in WT compared to CD mice harbouring the most common deletion found in WBS patients17,44. 
The results show the presence of luminal stenosis and compromised contractile responses to α1-adrenoceptor 
activation associated with increased NO signaling in CD mice ascending aortas.
Approximately half of WBS patients develop hypertension1,45. This fact has been correlated with higher levels 
of oxidative stress due to increased expression of Ncf119,28, which encodes the p47phox subunit of the NADPH oxi-
dase, the major source of superoxide anions in the vasculature46. However, a previous study of our group reported 
mild hypertension in 8-months old CD mice without increased levels of Ncf1 in the heart and the aorta17, suggest-
ing that CD mice may develop slight increases in blood pressure later in life. Notably, CD mice showed cardiac 
hypertrophy17,44 that was associated with increased levels of oxidative stress in the heart44. In the present study, 
wild-type CD
pEC50
PHE 6.57 ± 0.09 (15) 6.42 ± 0.20 (13)
U46619 6.92 ± 0.07 (3) 7.15 ± 0.09 (3)
ACh 7.38 ± 0.08 (15) 7.23 ± 0.07 (13)
Emax
PHE 4.19 ± 0.20 (15) 2.64 ± 0.28 (13)***
U46619 16.50 ± 0.81 (3) 14.80 ± 0.83 (3)
ACh 92.74 ± 2.53 (15) 92.49 ± 2.48 (13)
Table 1. pEC50 and Emax values for phenylephrine (PHE)- and U46619-induced contraction (mN) and 
acetylcholine (ACh)-induced relaxation (%) in the ascending aorta from wild-type and CD mice. Data are 
shown as mean ± SE. The number of animals is shown in parentheses. ***P < 0.001 versus wild-type by 
unpaired Student’s t-test.
Figure 5. Contractile responses in ascending aortas from wild-type and CD mice. (A) KCl 100 mM-induced 
contraction. (B) Concentration-response curves to phenylephrine. (C) Concentration-response curves to 
U46619. Results are the mean ± SEM from wild-type (n = 3–15) and CD (n = 3–13) mice. *P < 0.05 by Student’s 
t-test; **P < 0.01 by two-way ANOVA.
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young (3–4 months-old) CD mice did not show high systolic blood pressure nor greater levels of circulating or in 
situ aortic superoxide anions.
The proximal thoracic aorta (i.e. ascending aorta and aortic arch) from CD mice was longer and showed 
decreased elastin content, which is compatible with the elastin gene haploinsufficiency. In WBS, stenosis can 
occur diffusely, the most common sites being the thoracic aorta and the pulmonary vascular bed5. Supravalvular 
aortic stenosis is the most frequent cardiovascular anomaly, affecting approximately 70% of patients1,5. Aortic 
stenosis is a serious disease that if left untreated can increase the risk of suffering life-threatening complications, 
such as stroke6 and sudden death7. However, most experimental models of elastin haploinsufficiency do not 
show marked aortic luminal obstruction47. Notably, hemizygous deletion of the WBS critical region resulted in 
a moderate (50%) reduction in the ascending aorta lumen area compared to WT mice. Nevertheless, we did not 
measure histomorphometry in older animals to determine whether luminal obstruction subsequently progresses. 
Overall, young CD mice reproduce a crucial aspect of the human disorder, which is the presence of aortic stenosis 
close above the aortic root.
Relevant changes were observed in the functional characteristics of ascending aortas from CD mice. Thus, 
although endothelial-dependent relaxation to ACh was similar in either group, aortas from CD mice showed 
an increased contractile response to KCl-induced membrane depolarization together with compromised 
α1-adrenergic contractions to phenylephrine, despite contractions evoked by the thromboxane A2-analogue 
U46619 were unchanged. Notably, these attenuated α1-adrenergic contractions of WBS aortas were pres-
ent in spite of higher contractile responses to KCl, which suggests that although the smooth muscle contrac-
tile phenotype is able to produce powerful contractions, there is a lower aortic vasoconstriction specific to 
α1-adrenergic-mediated responses. Given the importance of the α1-adrenergic control of vascular tone, the lower 
response to phenylephrine could represent an adaptive mechanism to counteract luminal stenosis. Although 
there is little information about the functioning of the autonomic nervous system in WBS patients, a previous 
study reported that WBS children show increases in both heart rate and wave reflection values during the night, 
which may suggest abnormal sympathetic nervous system hyperactivity in WBS48. The results of the present study 
suggest that this hyperactivity might be counteracted by a lower response to aortic α1-adrenoceptor activation. 
Nevertheless, additional evidence is needed to demonstrate that the results obtained in the present ex vivo study 
can be translated in vivo.
Endothelial NO can exert an opposing modulatory influence on α1-adrenoceptor agonist vasoconstric-
tion24,49,50. eNOS plays an important role in the decreased ability of a vessel to respond to subsequent stimulation 
Figure 6. Influence of nitric oxide synthase (NOS) inhibition on ascending aortas phenylephrine contractions 
from wild-type and CD mice. Concentration-response curves to phenylephrine in the absence and presence of 
(A) the nonselective NOS inhibitor L-NAME (3 × 10−4 M), (B) the selective inducible NOS inhibitor 1400 W 
(10−5 M) and (C) the selective neuronal NOS inhibitor SMTC (10−6 M). Results are the mean ± SEM from wild-
type (n = 4–15) and CD (n = 4–13) mice. *P < 0.05, **P < 0.01 CD vs wild-type; #P < 0.05, ##P < 0.01 treated 
versus non-treated by two-way ANOVA.
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by the same agonist (NO-mediated desensitization)23. In addition, intense or sustained α1-adrenoceptor activ-
ity upregulates an endothelium-dependent nNOS pathway that attenuates α1-adrenoceptor-mediated contrac-
tions in the rat aorta24. This modulatory role of nNOS is associated with activation of the α1A-adrenoceptor 
subtype24 located in endothelial cells51. This effect can be physiologically relevant, as it might prevent significant 
increases in cardiac afterload. Therefore, our next objective was to determine if this mechanism was involved in 
the lower α1-adrenergic response observed in CD versus WT mice. Firstly, CD mice aortas showed increased 
aortic α1A-adrenoceptor expression, the subtype coupled to nNOS, and this change exhibited tissue specificity 
since it was not observed in the left ventricle (unpublished results). Secondly, our results pointed in the direction 
of a higher negative influence of NO on α1-adrenoceptor vasoconstriction in WBS, since compromised aortic 
contractions in CD mice were prevented by the non-selective NOS inhibitor L-NAME. In the vasculature, eNOS 
wild-type CD
Control
+L-NAME 3 × 10–4 
M +1400 W 10–5 M +SMTC 10–6 M Control
+L-NAME 3 × 10–4 
M +1400 W 10–5 M +SMTC 10–6 M
pEC50 6.57 ± 0.09 (15) 6.84 ± 0.15 (5) 6.38 ± 0.10 (4) 6.75 ± 0.18 (6) 6.42 ± 0.20 (13) 6.91 ± 0.25 (4) 6.33 ± 0.28 (4) 6.60 ± 0.30 (5)
Emax 4.19 ± 0.20 (15) 8.97 ± 0.59 (5)*** 4.31 ± 0.24 (4) 5.12 ± 0.42 (6)* 2.64 ± 0.28 (13)### 8.47 ± 0.94 (4)*** 2.64 ± 0.40 (4)# 4.19 ± 0.63 (5)*
Table 2. pEC50 and Emax values for phenylephrine-induced contraction (mN) in the ascending aorta from wild-
type and CD mice. Data are shown as mean ± SE. The number of animals is shown in parentheses. *P < 0.05, 
***P < 0.001 versus Control; #P < 0.05, ###P < 0.001 versus the same group in wild-type by unpaired Student’s 
t-test.
Figure 7. Genic and protein expression in thoracic aortas from wild-type and CD mice. (A) qPCR mRNA 
expression of Limk1, a gene contained in the Williams-Beuren syndrome critical region, and Adra1a 
(α1A-adrenoceptors). Results are the mean ± SEM from wild-type (n = 4) and CD (n = 5) mice. *P < 0.05; 
***P < 0.01 by Multiple t-test with Sidak-Bonferroni. (B) Western blot analysis for nNOS protein expression. 
Bar graphs show the results of densitometric analyses from pooled data for nNOS, iNOS, and eNOS protein 
expression. The molecular weight (kDa) of the protein is shown on the right side of the blot. Total protein was 
used as a loading control. Results are the mean ± SEM from wild-type (n = 5) and CD (n = 5) mice. *P < 0.05 
by Mann-Whitney U test. (C) Representative photomicrographs and quantification of immunofluorescence 
(red) for nNOS, iNOS, and eNOS in confocal microscopic aortic sections. Scale bar, 20 μm. Results are the 
mean ± SEM from wild-type (n = 8) and CD (n = 8) mice. *P < 0.05 by Student’s t-test.
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and nNOS isoforms of NOS are generally involved in regulatory or signaling pathways and play important roles in 
the modulation of vascular tone, whereas the iNOS isoform is related with inflammatory responses21. Inhibition 
of nNOS with SMTC, but not iNOS inhibition with 1400 W, significantly increased phenylephrine contractions 
in both strains, an effect that removed contractile impairments in CD mice. In addition, we detected an increased 
expression of nNOS in aortas from CD mice, whereas eNOS and iNOS expressions were similar to WT mice. 
Altogether, these results suggest a higher negative influence of NO on α1-adrenoceptor constriction in WBS 
mice, and propose that nNOS is a relevant NO source in these conditions (Fig. 8).
Augmented negative influence of NO in aortic adrenergic contractions might prevent excessive increases in 
cardiac afterload in the face of supravalvular aortic stenosis. Notably, impairment of tissue NO responsiveness is a 
main predictor of aortic stenosis development25–27, which provides additional evidence that NO may exert protec-
tive effects in WBS. Furthermore, clinical studies in patients with aortic stenosis suggest that nitrates can be used 
to lower blood pressure without excessive risk of reducing cardiac output or end-organ perfusion52, confirming a 
beneficial role for NO in this clinical setting.
In conclusion, our study reveals that ascending aorta obstruction coexist with functional alterations in a 
mouse model carrying the most common chromosomal deletion present in WBS patients. These findings sup-
port the clinical relevance of young CD mice to model moderate aortic stenosis associated with human WBS. The 
results show excessive nNOS-derived NO signaling that compromises ascending aorta α1-adrenergic contrac-
tions. Therefore, increased nNOS signaling may act as a physiological ‘brake’ against the detrimental effects of 
stenosis. We suggest that early detection and monitoring of thoracic aorta dysfunction would offer the potential 
for timely intervention in this syndrome.
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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